Clinical Trial Results: Prostate Cancer

Home

Results

Protocol Registry

Trial Results

IFPMA

Background

Links

About this Registry

This database is populated with information on the results of Roche-sponsored clinical trials.

What are the differences between clinical trial phases?

Why has Roche decided to have its own registry and results database?

More FAQs

Glossary of Terms

Phase Definitions

Field Definitions

Clinical Trial Policy

Site Provided by Thomson CenterWatch

Clinical Trial Results: Prostate Cancer

Product Name: Epothilone D
Date of Report: To be Published
Phase: II
A Study of Epothilone D in Patients with Metastatic Prostate Cancer

Product Name: pertuzumab
Date of Report: 1/1/2006
Phase: II
An open-label, phase II, multicenter study to evaluate the efficacy and safety of a recombinant humanized antibody to HER2 (pertuzumab) administered every 3 weeks to patients with hormone-refractory prostate cancer who have not been treated with chemotherapy.


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement

Home

Trial Results updated: July 16, 2008 at 11:06:40 AM